Workflow
磷化工
icon
Search documents
粤开市场日报-20260225
Yuekai Securities· 2026-02-25 07:45
证券研究报告 | 策略点评 2026 年 02 月 25 日 投资要点 分析师:孟之绪 执业编号:S0300524080001 电话: 邮箱:mengzhixu@ykzq.com 投资策略研究 粤开市场日报-20260225 今日关注 指数涨跌情况:今日 A 股主要指数普遍收涨。截止收盘,沪指上涨 0.72%,收 报 4147.23 点;深证成指涨 1.29%,收报 14475.87 点;创业板指涨 1.41%, 收报 3354.82 点;科创 50 指数涨 0.54%,收报 1473.28 点。总体上,全天个 股涨多跌少,Wind 数据显示,全市场 3742 只个股上涨,仅 1609 只个股下跌, 127 只个股收平。沪深两市今日成交额合计 24625 亿元,较上个交易日放量 2605 亿元。 行业涨跌情况:今日申万一级行业涨多跌少,钢铁、有色金属、建筑材料、 房地产、基础化工等行业领涨,涨幅分别为 4.69%、3.48%、2.75%、2.53%、 2.16%,仅有传媒、银行领跌,跌幅分别为 1.15%、0.46%。 概念板块涨跌情况:今日涨幅居前的概念板块为稀土、稀有金属精选、磷化 工、小金属、稀土永磁、 ...
2月24日A股市场点评:马年首日收涨
Zhongshan Securities· 2026-02-24 12:07
[tabl中e_山pa每ge日1点] 评 [table_subject] 2026 年 2 月 24 日 证券研究报告·中山每日点评 马年首日收涨 ——2 月 24 日 A 股市场点评 [中ta山bl证e_券inv研es究t]所 [[分ttaa析bbll师ee__:rree唐ssee晋aarr荣cchh]] 登记编号:S0290517120002 邮箱:tangjr@zszq.com 分析师:方鹏飞 登记编号:S0290519010001 邮箱:fangpf@zszq.com 分析师:葛淼 登记编号:S0290521120001 邮箱:gemiao@zszq.com 1.市场整体表现 表 1 主要指数涨跌幅度 | 指数名称 | 涨跌幅(%) | 指数名称 | 涨跌幅(%) | | --- | --- | --- | --- | | 上证指数 | 0.87 | 北证 50 | 0.37 | | 深证成指 | 1.36 | 万得全 A | 1.06 | | 沪深 300 | 1.01 | 中证 500 | 1.12 | | 科创 50 | -0.34 | 红利指数 | 1.86 | 资料来源:Wind,中山证券研 ...
风语筑6天4板,可燃冰概念领涨丨强势个股
二、强势概念板块 根据A股概念涨跌幅与所对应的股票池综合分析,涨幅靠前的三个概念板块分别为:可燃冰、培育钻石与草甘膦。排名前10位的概念板块相关数据见下表: | 概念名称 | 涨跌幅(%) | 涨停成分股占比(%) | 上涨成分股占比(%) | 下跌成分股占比(%) | | --- | --- | --- | --- | --- | | 可燃冰 | 7.38 | 28.57 | 100.0 | 0.0 | | 培育钻石 | 6.16 | 16.67 | 94.44 | 5.56 | | 草甘脾 | 5.56 | 11.11 | 100.0 | 0.0 | | 钛白粉概念 | 5.47 | 20.0 | 100.0 | 0.0 | | 页岩气 | 5.34 | 12.0 | 100.0 | 0.0 | | 磷化工 | 5.18 | 20.69 | 93.1 | 6.9 | | 金属铝 | 4.93 | 13.16 | 97.37 | 2.63 | | 俄乌冲突概念 | 4.89 | 20.55 | 97.26 | 2.74 | | 化肥 | 4.52 | 12.5 | 97.22 | 2.78 | | 金属锌 ...
粤开市场日报-20260224
Yuekai Securities· 2026-02-24 07:51
证券研究报告 | 策略点评 2026 年 02 月 24 日 投资要点 分析师:孟之绪 执业编号:S0300524080001 电话: 邮箱:mengzhixu@ykzq.com 投资策略研究 粤开市场日报-20260224 今日关注 指数涨跌情况:今日 A 股主要指数多数收涨。截止收盘,沪指上涨 0.87%,收 报 4117.41 点;深证成指涨 1.36%,收报 14291.57 点;创业板指涨 0.99%, 收报 3308.26 点;科创 50 指数跌 0.34%,收报 1465.37 点。总体上,全天个 股涨多跌少,Wind 数据显示,全市场 4003 只个股上涨,仅 1388 只个股下跌, 86 只个股收平。沪深两市今日成交额合计 22021 亿元,较上个交易日放量 2194 亿元。 行业涨跌情况:今日申万一级行业涨多跌少,石油石化、建筑材料、基础化 工、有色金属、煤炭等行业领涨,涨幅分别为 5.53%、3.71%、3.45%、3.31%、 3.10%,传媒、计算机、商贸零售、食品饮料、非银金融等行业领跌,跌幅分 别为 3.20%、1.81%、1.46%、0.86%、0.42%。 概念板块涨跌情况: ...
马年开门红!A股三大股指集体上涨
Zhong Guo Xin Wen Wang· 2026-02-24 07:29
截至收盘,沪指涨0.87%报4117.41点;深成指涨1.36%报14291.57点;创业板指涨0.99%报3308.26点。 中新网2月24日电2月24日,马年首个交易日,A股三大股指集体上涨。 A股三大股指收盘表现。 全市场超4000只个股上涨,全天成交额约2.2万亿元,较前一交易日有所放量。 盘面上,能源设备、石油天然气、海运、化肥农药等行业板块涨幅居前;概念板块方面,培育钻石、玻 璃纤维、磷化工、油气开采等表现亮眼。 (文章来源:中国新闻网) ...
洛阳钼业涨2.93%,成交额57.45亿元,人气排名10位!后市是否有机会?附走势预测
Xin Lang Cai Jing· 2026-02-11 07:44
Core Viewpoint - Luoyang Molybdenum Co., Ltd. is experiencing a positive market response, with a stock price increase of 2.93% and a trading volume of 5.745 billion yuan, indicating strong investor interest and market activity [1]. Company Overview - Luoyang Molybdenum is primarily engaged in the mining and processing of non-ferrous metals, including molybdenum, tungsten, cobalt, and copper, and is recognized as one of the top five molybdenum producers globally and the largest tungsten producer [3][4]. - The company has a comprehensive integrated industrial chain and is also the second-largest producer of cobalt and niobium globally, as well as a leading copper producer [3][4]. Production and Revenue Insights - The company holds an 80% stake in the NPM copper-gold mine in Australia, with gold production guidance for 2023 set to increase by 56% to 69% compared to 2022, projecting an output of 25,000 to 27,000 ounces [3]. - In 2025, Luoyang Molybdenum plans to complete the acquisition of the Odin Mining project in Ecuador, aiming for production by 2029 [3]. - The company reported a revenue of 145.485 billion yuan for the first nine months of 2025, a decrease of 5.99% year-on-year, while net profit attributable to shareholders increased by 72.61% to 14.280 billion yuan [9]. Market Position and Shareholder Information - As of September 30, 2025, the company had 304,200 shareholders, reflecting an increase of 28.08% from the previous period [9]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 695 million shares, an increase of 47.472 million shares [9]. Financial Performance - The company has distributed a total of 21.562 billion yuan in dividends since its A-share listing, with 10.576 billion yuan distributed over the past three years [9].
和邦生物涨2.04%,成交额1.59亿元,主力资金净流入227.97万元
Xin Lang Cai Jing· 2026-02-11 02:36
Core Viewpoint - The stock of Hebang Biotechnology has shown a positive trend with a year-to-date increase of 10.62%, reflecting investor interest and market activity [1]. Group 1: Stock Performance - As of February 11, the stock price of Hebang Biotechnology reached 2.50 CNY per share, with a trading volume of 1.59 billion CNY and a market capitalization of 22.079 billion CNY [1]. - The stock has experienced a 0.81% increase over the last five trading days, a 14.68% increase over the last 20 days, and a 2.46% increase over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 59.5468 million CNY on January 28, accounting for 14.52% of total trading volume [1]. Group 2: Company Overview - Hebang Biotechnology, established on August 1, 2002, and listed on July 31, 2012, is located in Leshan, Sichuan Province, and specializes in the manufacturing of pesticides, fine chemicals, and various glass products [2]. - The company's revenue composition includes 85.89% from chemical products, 17.61% from photovoltaic glass and other products, 6.74% from mineral products, and 5.02% from other businesses [2]. - The company operates within the basic chemical industry, specifically in the agricultural chemical sector, and is involved in concepts such as chemical raw materials and phosphate chemicals [2]. Group 3: Financial Performance - For the period from January to September 2025, Hebang Biotechnology reported a revenue of 5.927 billion CNY, a decrease of 13.02% year-on-year, and a net profit attributable to shareholders of 93.1085 million CNY, down 57.93% year-on-year [2]. - The company has distributed a total of 1.205 billion CNY in dividends since its A-share listing, with 553 million CNY distributed over the past three years [3]. Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders for Hebang Biotechnology was 196,500, a decrease of 1.99% from the previous period, with an average of 44,939 shares held per shareholder, an increase of 2.03% [2]. - Notable institutional shareholders include Penghua CSI Sub-Sector Chemical Industry Theme ETF and Southern CSI 500 ETF, with significant holdings and changes in share quantities [3].
洛阳钼业涨1.96%,成交额42.36亿元,人气排名25位!后市是否有机会?附走势预测
Xin Lang Cai Jing· 2026-02-09 07:25
Core Viewpoint - Luoyang Molybdenum Co., Ltd. is experiencing a significant increase in gold production and is strategically expanding its operations in the precious metals sector, while also maintaining a strong position in various metal markets [2][3]. Group 1: Company Overview - Luoyang Molybdenum Co., Ltd. is primarily engaged in the mining, selection, smelting, and deep processing of precious metals such as molybdenum, tungsten, and gold, and has a comprehensive integrated industrial chain [2][7]. - The company is one of the top five molybdenum producers globally and the largest tungsten producer, as well as the second-largest cobalt and niobium producer, and a leading copper producer [2][3]. - The company is also the second-largest producer of phosphate fertilizer in Brazil, with a complete phosphate industry chain [3][7]. Group 2: Production and Financial Performance - The company holds an 80% stake in the NPM copper-gold mine in Australia, with gold production guidance for 2023 set to increase by 56% to 69% compared to 2022, reaching between 25,000 to 27,000 ounces [2]. - For the first nine months of 2025, Luoyang Molybdenum achieved a revenue of 145.49 billion yuan, a decrease of 5.99% year-on-year, while net profit attributable to shareholders increased by 72.61% to 14.28 billion yuan [8]. - The company has distributed a total of 21.56 billion yuan in dividends since its A-share listing, with 10.58 billion yuan distributed in the last three years [8]. Group 3: Market Activity and Stock Performance - On February 9, Luoyang Molybdenum's stock rose by 1.96%, with a trading volume of 4.236 billion yuan and a market capitalization of 479.66 billion yuan [1]. - The stock has seen a net outflow of 117 million yuan from major investors, indicating a reduction in holdings over the past three days [4][5]. - The average trading cost of the stock is 18.69 yuan, with the current price approaching a resistance level of 22.70 yuan, suggesting potential for upward movement if this level is surpassed [6].
粤开市场日报-20260206-20260206
Yuekai Securities· 2026-02-06 07:45
Market Overview - The A-share major indices mostly closed lower today, with the Shanghai Composite Index down 0.25% at 4065.58 points, the Shenzhen Component Index down 0.33% at 13906.73 points, the ChiNext Index down 0.73% at 3236.46 points, and the Sci-Tech 50 Index down 0.71% at 1422.41 points [1] - Overall, the market saw mixed performance with 2748 stocks rising and 2545 stocks falling, while 180 stocks remained flat. The total trading volume in the Shanghai and Shenzhen markets was 21,457 billion yuan, a decrease of 305 billion yuan compared to the previous trading day [1] Industry Performance - Among the Shenwan first-level industries, sectors such as petroleum and petrochemicals, basic chemicals, and electric equipment led the gains, with increases of 2.55%, 2.05%, and 1.27% respectively. Conversely, industries like food and beverage, defense and military, and social services experienced declines, with drops of 1.86%, 1.66%, and 1.37% respectively [1] Concept Sector Performance - The concept sectors that saw the highest gains today included lithium battery electrolyte, lithium battery anode, and solid-state batteries, among others. Notably, sectors such as liquor, cross-strait integration, and advanced packaging experienced pullbacks [2]
金诚信大跌5.23%,成交额2.07亿元,主力资金净流入295.85万元
Xin Lang Cai Jing· 2026-01-30 01:53
Group 1 - The core viewpoint of the news is that Jinchengxin has shown significant stock performance and financial growth, with a notable increase in revenue and net profit year-on-year [2][3]. - As of January 30, Jinchengxin's stock price decreased by 5.23% to 83.21 CNY per share, with a total market capitalization of 51.905 billion CNY [1]. - The company has experienced a stock price increase of 9.27% year-to-date, with a 32.67% increase over the past 60 days [1]. Group 2 - For the period from January to September 2025, Jinchengxin achieved operating revenue of 9.933 billion CNY, representing a year-on-year growth of 42.50%, and a net profit attributable to shareholders of 1.753 billion CNY, up 60.37% [2]. - The company has distributed a total of 768 million CNY in dividends since its A-share listing, with 477 million CNY distributed over the past three years [3]. - As of September 30, 2025, Jinchengxin's shareholder count increased by 4.67% to 22,100, while the average circulating shares per person decreased by 4.46% to 28,276 shares [2].